Also trades as: CBTE (OTC) · $vol 0M
INTI OTC
Inhibitor Therapeutics, Inc.
1W: -2.0%
1M: +10.1%
3M: +24.8%
YTD: +109.0%
1Y: +96.0%
3Y: +188.2%
5Y: -69.4%
$0.10
-0.00 (-2.00%)
Weekly Expected Move ±41.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-12-19
Earliest Filing
2025-10-27
Latest Filing
partner: 2
investor: 2
customer: 1
licensee: 1
Counterparties (Filed by INTI)
6 relationshipsCompanies named in INTI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Frameshift Management, Inc. | — | partner | Consultant providing biostatistics and regulatory consulting services | 2025-10-27 | View |
| Inhibitor Therapeutics, Inc. | INTI | customer | Client engaging consultant for clinical study re-analysis and regulatory support | 2025-10-27 | View |
| Johns Hopkins University | — | licensee | Granted exclusive worldwide patent rights to Inhibitor Therapeutics, Inc. | 2023-12-14 | View |
| Mayne Pharma Ventures Pty Ltd | — | partner | Significant minority stockholder and majority shareholder involved in settlement of derivative and class actions; entere | 2022-12-19 | View |
| Hedgepath, LLC | — | investor | Significant minority stockholder that filed the derivative action against the Company's directors and officers. | 2022-12-19 | View |
| Samuel P. Sears | — | investor | Company stockholder who filed the putative class action lawsuit against the Company's directors and officers. | 2022-12-19 | View |
Recent 8-K Filings (12)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-18 | Officer/Director Change; Shareholder Vote | View | |
| 2026-04-01 | Other Events; Exhibits | View | |
| 2026-04-01 | Regulation FD; Exhibits | View | |
| 2026-02-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-27 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2023-12-14 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2023-10-18 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2023-05-31 | Departure/Election of Directors; Appointment of Officers | View | |
| 2022-12-19 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Changes in C | Agreement | View |
| 2022-09-15 | Other Events; Financial Statements and Exhibits | View | |
| 2022-06-03 | Departure/Election of Directors; Appointment of Officers | View | |
| 2022-01-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR